Common Erectile Dysfunction Drug Linked to Glaucoma, Researchers Say

Healthline News
Published
Common Erectile Dysfunction Drug Linked to Glaucoma, Researchers Say

The short version

  • Fred De Noyelle /GODONG/Getty Images A new study suggests that people who take the erectile dysfunction drug Cialis for urinary tract issues may have a higher risk of glaucoma…
  • Men who take tadalafil and have glaucoma risk factors should receive regular eye exams, the researchers say.
  • The overall risk of eye disease from occasional use of Cialis to treat erectile dysfunction is low.
  • A commonly prescribed erectile dysfunction drug may raise the risk of glaucoma for males with an enlarged prostate who take the medication, according to a new study.
  • The researchers suggest that people taking tadalafil on a daily basis over a long period of time have regular eye exams, particularly men who already have glaucoma risk factors.

The story

A common erectile dysfunction drug prescribed for men with enlarged prostates is linked to a higher risk of glaucoma. Fred De Noyelle /GODONG/Getty Images
  • A new study suggests that people who take the erectile dysfunction drug Cialis for urinary tract issues may have a higher risk of glaucoma, a vision-threatening eye disease.
  • Men who take tadalafil and have glaucoma risk factors should receive regular eye exams, the researchers say.
  • The overall risk of eye disease from occasional use of Cialis to treat erectile dysfunction is low.

A commonly prescribed erectile dysfunction drug may raise the risk of glaucoma for males with an enlarged prostate who take the medication, according to a new study.

Researchers say that men taking the medication tadalafil, which is sold under the brand name Cialis, on a long-term basis to treat urinary urgency and urinary frequency associated with an enlarged prostate could have a higher likelihood of developing glaucoma, a serious eye condition that can affect vision.

The researchers suggest that people taking tadalafil on a daily basis over a long period of time have regular eye exams, particularly men who already have glaucoma risk factors. These include a family history of the disease or already having ocular hypertension, a condition that causes elevated pressure inside the eye.

They recently published their findings in the British Journal of Ophthalmology.

S. Adam Ramin, MD, a urologist, urologic oncologist, and medical director of Urology Cancer Specialists in Los Angeles, said Cialis has been prescribed for years to help urinary tract issues.

He said the risk of glaucoma is still low, but it is something patients should be aware of.

“The risk is relatively small, but it’s important to discuss this with patients,” Ramin told Healthline.

He added that males who occasionally take Cialis to treat erectile dysfunction should not be concerned because they aren’t using the medication on a daily basis.

Craig Comiter, MD, a professor of urology at Stanford University, agreed that the risks are low.

“It’s important to note that the absolute risk was less than 1% greater with daily tadalafil,” he told Healthline. 

“For certain, someone with a family history or pre-existing glaucoma or other risk factors should be monitored with ophthalmologic care,” he added. “It’s not obvious that taking this drug changes the required monitoring.”

Officials at Eli Lilly and Company, the manufacturers of Cialis, did not respond to a request for comment on the new research.

How erectile dysfunction drugs may cause vision problems

Tadalafil belongs to a class of medications known as phosphodiesterase type 5 inhibitors (PDE5i).

This group also includes sildenafil, which is sold under the brand name Viagra.

According to the American Academy of Ophthalmology, erectile dysfunction drugs, such as tadalafil and sildenafil, may cause relatively minor vision problems such as light sensitivity, blurry vision, a blue-green tint to vision, and decreased color vision.

For their new study, researchers analyzed medical records from the TriNetX Analytics Network of more than 70,000 males ages 40 and older. None of the participants had a history of glaucoma.

Between January 2012 and December 2022, half of the subjects received tadalafil for urinary tract symptoms for up to 5 years. The other participants were taking the drug.

The researchers compared the two groups over five years, examining the likelihood of the participants developing glaucoma or ocular hypertension, or if they began treatment for glaucoma.

The analysis found that males who were prescribed tadalafil were 22% more likely to develop glaucoma than those who had not received the drug.

Males who took tadalafil were also 32% more likely to develop ocular hypertension, 33% more likely to develop primary open-angle glaucoma, and 33% more likely to begin glaucoma treatment.

The researchers noted that most of the study participants were white, which might limit how confidently the findings can be applied to men from other ethnic backgrounds.

They added that their research was observational, so it cannot demonstrate that tadalafil itself caused the increased eye risks.

Ramin said that the risks to any individual patient are relatively small, especially for someone who doesn’t use tadalafil for extended periods.

He added that are medications that aren’t PDESi drugs that can be used to treat urinary tract issues.

“There are alternatives,” Ramin said.

“There are multiple treatments for lower urinary tract symptoms associated with benign prostatic enlargement,” added Comiter. “All patients should be treated with behavioral modification and, if indicated, can try different classes of pharmacotherapy.”

“Each of these medications has their own side effect profile and, based on a patient’s history and risk factors for concomitant disease, the patient and physician should exercise shared decision-making and figuring out the best pharmacologic treatment,” he said.

“If pharmacologic treatment is either unsuccessful or contraindicated, surgical intervention is often successful,” Comiter noted.

What to know about glaucoma

Glaucoma is a condition generally caused by abnormally high pressure inside the eye.

The pressure can cause damage to the optic nerve, in particular eroding optic nerve tissue. That erosion can lead to vision loss and even blindness.

The most common form of glaucoma is open-angle glaucoma.

There are usually no symptoms in the early stages of this type of glaucoma except for a gradual loss of vision.

The vision loss, in fact, may occur so slowly that a person may not experience any other symptoms or signs of this damage before it becomes permanent and vision loss cannot be restored.

More than 4 million people in the United States are estimated to have glaucoma. About half are unaware they have the condition.

About 80 million people worldwide have glaucoma. It is a leading cause of blindness globally.

However, in the United States, blindness rarely occurs from glaucoma due to early detection and advanced treatments.

Glaucoma can affect people of any age, but people over the age of 60 are at higher risk. So are African-Americans, people with diabetes, and people with severe nearsightedness.

There is no cure for glaucoma, but treatments can slow or even halt the progression of the condition. Treatments for glaucoma include:

  • medications, including tablets and eye drops
  • laser treatment to reduce eye pressure
  • surgery to help drain fluid buildup behind the eye

Ramin said it’s important for people to get regular eye exams so they can have their eye pressure tested for signs of glaucoma.

Read the full story at Healthline NewsOriginal

Related Markets

All Markets
View full chart →
View Full Chart

Market data may be delayed. Not financial advice.

Powered by Gab AI

The Story At A Glance

Reading this article now — analysis appears below

Reading the article

💡 AI analysis provides alternative perspectives on current events

More to read

Recent stories from across the outlets Alto indexes.

Questions Alto can answer

From this story — each link opens a live data page or a tool already filled in.

  1. What is $100 from 1990 worth today?CPI-adjusted dollars — result on the next page
  2. Where does a $75,000 household income rank nationally?Census percentile — national and state
  3. What federal tax bracket is $80,000 (single)?Marginal and effective rate on the next page
  4. What's Alto covering on the Health desk?Latest headlines on this beat

All toolsAll topicsSource directoryStory timelinesHeadline comparisonSearchMost read

From Gab Shop

Official merchandise. Every order funds free speech infrastructure.

Shop all products

Install Alto on your phone

Add Alto to your home screen for breaking news — no app store, no account.

  1. Step 1Open alto.gab.com in SafariMust be Safari — not Chrome or in-app browsers
  2. Step 2Tap the Share buttonSquare with an arrow, at the bottom of Safari
  3. Step 3Tap "More"If you don’t see Add to Home Screen yet
  4. Step 4Tap "Add to Home Screen"Scroll the share sheet if you need to
  5. Step 5Tap "Add"Alto appears on your home screen like any other app.
gab

Ask Health Questions Freely

Compare notes on treatments, studies, and outcomes without a warning label pasted over the thread.

What Makes Gab Different

We're not just another social network. We're a platform built on principles that matter.

Freedom of Speech & Reach

All First Amendment protected speech is welcome. No algorithmic throttling or shadow banning.

Family-Friendly Platform

We maintain a clean environment. Explicit adult content is strictly prohibited.

Western Nations Only

Third-world IPs are blocked. No scammers, no spam farms. Built for Western civilization.

Funded By Users

Our users are our investors and customers. You're not the product being sold.

Battle Tested

A decade of standing strong. Banned from app stores, banks—and still here.

American Owned & Operated

We reject foreign censorship demands. Built by Americans, for free people.

Support Alto & Gab

Alto is funded entirely by readers like you. Your donation helps us continue delivering curated news from a right-wing Christian Nationalist perspective, powered by Gab AI.